True Link Financial Advisors, LLC Amgen Inc Transaction History

True Link Financial Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$224.46 - $253.15 $218,848 - $246,821	975 New	975 $220,000
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $54,817 - $60,642	-250 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$198.88 - $227.6 $73,187 - $83,756	-368 Reduced 59.55%	250 $56,000
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $6,792 - $7,958	-32 Reduced 4.92%	618 $131,000
Q2 2021 Aug 19, 2021	BUY	$233.58 - $259.14 $10,043 - $11,143	43 Added 7.08%	650 $158,000
Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $131,342 - $156,405	607 New	607 $140,000

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of True Link Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on True Link Financial Advisors, LLC with notifications on news.